U.S. stock markets looked poised for moderately higher opening on Friday, awaiting key economic data on housing starts. Wall Street expects a decline in sales after jumping to 6.46 million in January. Among companies in focus, shares of Amgen dropped 4.2% in pre-open trade after it halted a study due to poor survival in patients that used Vectibix along with Genentech''''s Avastin and chemotherapy to treat colorectal cancer.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
More:
